News

$13.7M grant from National Cancer Institute will support several projects on breast and pancreatic cancers

As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...

UC Riverside-led study shows inhibiting two host cell proteases can accomplish the task

NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors

UC Riverside researchers develop new drugs that target therapeutically relevant protein surfaces

Novel agents 135H11 and 135H12 move research closer to drug development

UC Riverside’s Maurizio Pellecchia receives grants totaling nearly $2.5 million from National Academy of Sciences, Engineering, and Medicine; and National Institute of Neurological Disorders and Stroke

A UCR research team has discovered a way for chemotherapy drug paclitaxel to target migrating cancer cells